Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Compression Therapy Market analysis
Part of: Compression Therapy Market (Global)

The Europe Compression Therapy Market was valued at $1341.1 Million in 2025 and projected to reach to $1715.3 Million by 2030, representing a compound annual growth rate of 5.0%. Europe's compression therapy market is characterized by steady maturation and consolidation, driven by an aging population and rising awareness of venous and lymphatic disorders.

Europe Compression Therapy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Compression Therapy Market Trends and Insights

  • Europe represents a mature and well-established market for compression therapy solutions, driven by aging demographics, rising prevalence of venous and lymphatic disorders, and strong healthcare infrastructure across the region.
  • The market in Europe benefits from high awareness of compression therapy benefits and robust reimbursement policies in key countries. During the forecast period from 2025 to 2030, Europe's compression therapy market will be supported by increasing adoption of advanced compression garments, growing demand for home-based care solutions, and expanding clinical applications.
  • Europe's healthcare systems continue to prioritize evidence-based compression therapy for conditions such as deep vein thrombosis, chronic venous insufficiency, and lymphedema.
  • The region's focus on preventive healthcare and patient mobility enhancement positions Europe as a significant growth market within the global compression therapy landscape..

Key Market Statistics

  • CAGR (2025-2030) 5.0% CAGR
  • Market Size, 2025 ~USD 1341.1 Million
  • Forecast, 2030 ~USD 1715.3 Million
  • Geography Europe

Europe Compression Therapy Market Overview

Mature Market Leadership :

Europe commands a significant share of the global compression therapy market, valued at USD 1,341.1 million in 2025. Germany leads as the largest European market with USD 488.7 million, followed by France at USD 267.3 million, reflecting strong healthcare adoption and reimbursement frameworks.

Aging Population Driving Demand :

Europe's rapidly aging demographic is a primary growth catalyst, with increasing prevalence of venous insufficiency, lymphedema, and post-thrombotic syndrome. Healthcare systems across the region are investing in preventive and therapeutic compression solutions to manage chronic conditions.

Robust Healthcare Infrastructure :

Well-established healthcare systems, strong regulatory frameworks, and high insurance coverage across European nations support consistent market expansion. Reimbursement policies for compression garments and devices remain favorable, particularly in Germany, France, and the UK.

Steady Growth Trajectory :

The European market is projected to grow from USD 1,341.1 million in 2025 to USD 1,715.3 million by 2030, representing a 5.0% CAGR. This moderate but stable growth reflects market maturity and sustained clinical demand for compression therapy solutions.

Europe Compression Therapy Market Dynamics

  • The region benefits from advanced healthcare infrastructure, strong regulatory oversight, and favorable reimbursement policies that support consistent adoption of compression solutions across hospitals, clinics, and home care settings. Looking ahead to 2030, the European market will continue to expand at a 5.0% CAGR, supported by technological innovations in fabric and design, increasing prevalence of chronic conditions, and growing patient education initiatives.
  • Key growth opportunities lie in emerging Eastern European markets and the development of smart compression garments integrated with digital health monitoring capabilities..

Related Ecosystem

Medical Devices

Top Technologies
    Top Companies

      Key Takeaways

      • Europe's compression therapy market is valued at USD 1,341.1 million in 2025 and will reach USD 1,715.3 million by 2030, representing a 5.0% CAGR.
      • Europe's aging population and high prevalence of chronic venous diseases drive sustained demand for compression therapy solutions across the region.
      • Strong healthcare infrastructure and favorable reimbursement policies in Europe support market expansion and patient access to compression therapy.
      • Europe's market growth is fueled by innovation in compression garment technology and increasing adoption of home-based care models through 2030.

      Compression Therapy Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment LYMPHEDEMA TREATMENT (Application)
      Forecast Period 2025–2030
      Growth Rate CAGR of 5.5% from 2025 to 2030
      Largest Segment STATIC COMPRESSION THERAPY (Technique)
      Market Size Base Year (Billions) ~USD 4.51 (2025)
      Revenue Forecast (Billions) ~USD 5.9 (2030)
      Segments Covered Product, Technique, Application, Distribution Channel, Type

      Europe Compression Therapy Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Compression Bandages
      • Compression Braces
      • Compression Stockings
      • Compression Tapes
      • Compression Wraps
      • Other Compression Garments
      • Pneumatic Compression Devices

      By Technique

      • Dynamic Compression Therapy
      • Static Compression Therapy

      By Application

      • Deep Vein Thrombosis Treatment
      • Leg Ulcer Treatment
      • Lymphedema Treatment
      • Other Applications
      • Varicose Vein Treatment

      By Distribution Channel

      • E-Commerce Platforms
      • Home Care Settings
      • Hospitals & Clinics
      • Pharmacies & Retailers

      By Type

      • Class I
      • Class Ii
      • Class Iii
      • Intermittent Compression Devices
      • Sequential Compression Devices

      EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      DEEP VEIN THROMBOSIS TREATMENT240.6251.3262.4275.2289.3304.8321.7340.15.3
      LEG ULCER TREATMENT269.8280.9292.5305.7320.4336.5354.1373.25
      LYMPHEDEMA TREATMENT245.9258.1270.8285.2301.1318.6337.7358.65.8
      OTHER APPLICATIONS134.7139.2144149.4155.5162169.2176.94.2
      VARICOSE VEIN TREATMENT344.7357.8371.4387404.4423.3443.9466.34.7
      TOTAL1235.71287.41341.11402.51470.71545.21626.51715.35

      Target Audience

      • Medical Device Manufacturers : Compression therapy companies need detailed European market data to assess market size, growth potential, and competitive positioning. Country-level insights enable informed decisions on market entry, product localization, and regulatory compliance strategies.
      • Healthcare Providers & Hospital Networks : European hospitals and clinics require market intelligence to understand compression therapy adoption trends, reimbursement policies, and procurement opportunities. Data supports clinical protocol development and supply chain optimization.
      • Investors & Private Equity Firms : Investment professionals evaluating compression therapy companies or healthcare portfolios need comprehensive European market analysis. Market sizing, growth forecasts, and regional dynamics inform valuation, due diligence, and exit strategy planning.
      • Distributors & Healthcare Retailers : European distributors and pharmacy networks require market data to identify growth opportunities, assess competitive intensity, and optimize product portfolio decisions. Country-specific insights guide inventory management and sales forecasting.
      • Healthcare Consultants & Analysts : Management consultants and market research professionals need authoritative European compression therapy data to support client engagements, strategic recommendations, and market assessments across the healthcare and medical device sectors.

      Key Companies in the Europe Compression Therapy Market

      CompanyHQOwnershipStrongest segments
      DEVON MEDICAL PRODUCTSUnited StatesPrivate CompanyPneumatic compression (dynamic),Stockings (static),Wraps and bandages (static),
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyBandage,Wraps,Stockings,
      BEIERSDORF AGGermanyPublic CompanyBandages,Wraps,Stockings,
      SOLVENTUM CORPORATION (3M)United States
      ENOVIS CORPORATIONUnited StatesPublic CompanyStatic compression (bandages, wraps, stockings, tapes),Braces with integrated compression,Dynamic/pneumatic compression systems,
      BSN MEDICAL (A SUBSIDIARY OF ESSITY)Sweden
      CARDINAL HEALTHUnited StatesPublic CompanyBandages & Wraps,Stockings,Tapes,
      TACTILE MEDICALUnited StatesPublic CompanyPneumatic compression systems (Flexitouch Plus, Entre Plus, Nimbl),Software and digital engagement (Kylee app, connectivity, services),Non-compression respiratory therapy (AffloVest),
      CONVATEC INC.United KingdomPublic CompanyStatic compression (bandages, wraps, stockings, tapes, braces),Dynamic compression (pneumatic devices),
      MEDI GMBH & CO. KGTaiwanPublic CompanyStockings (Static),Wraps & Braces (Static),Bandages & Tapes (Static),
      PAUL HARTMANNGermanyPublic CompanyBandages (compression, universal, zinc paste, padding),Wraps and Stockings,Tapes and Braces,
      SMITH+NEPHEWUnited KingdomPublic CompanyBandage,Wraps,Stockings,

      DEVON MEDICAL PRODUCTS

      Devon Medical Products is a private medical products company founded in 2005 and based in the United States.

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States with 64,200 employees.

      BEIERSDORF AG

      Beiersdorf AG is a German public company founded in 1882 with 21,589 employees, operating in the healthcare and consumer goods sectors.

      SOLVENTUM CORPORATION (3M)

      Insufficient data available to provide a business description for Solventum Corporation (3M).

      ENOVIS CORPORATION

      Enovis Corporation is a public medical technology company founded in 1995 in the United States with 7,802 employees.

      BSN MEDICAL (A SUBSIDIARY OF ESSITY)

      Insufficient data available to provide a business description for BSN Medical (a subsidiary of Essity).

      CARDINAL HEALTH

      Cardinal Health is a public healthcare services and pharmaceutical distribution company founded in 1979 in the United States with 55,392 employees.

      TACTILE MEDICAL

      Tactile Medical is a public medical device company founded in 1995 in the United States with 1,086 employees.

      CONVATEC INC.

      ConvaTec Inc. is a public medical products and healthcare company founded in 1978 in the United Kingdom with 10,910 employees.

      MEDI GMBH & CO. KG

      Medi GmbH & Co. KG is a public medical device company founded in 1997 based in Taiwan with 17,449 employees.

      PAUL HARTMANN

      Paul Hartmann is a German public healthcare company founded in 1818 with 10,066 employees.

      SMITH+NEPHEW

      Smith+Nephew is a public medical devices and healthcare company founded in 1856 in the United Kingdom with 16,988 employees.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 2191.8 Million · 5.4% wtd CAGR ·
      Asia Pacific
      ~USD 1280.5 Million · 7% wtd CAGR ·
      Latin America
      ~USD 413.5 Million · 4.4% wtd CAGR ·
      Middle East & Africa
      ~USD 251.3 Million · 3.8% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 488.7 Million
      FranceUSD 267.3 Million
      UKUSD 67.4 Million
      ItalyUSD 47.6 Million
      SpainUSD 52.7 Million
      Rest Of EuropeUSD 103.1 Million

      Country market size visualization

      Germany
      USD 488.7 Million
      France
      USD 267.3 Million
      UK
      USD 67.4 Million
      Italy
      USD 47.6 Million
      Spain
      USD 52.7 Million
      Rest Of Europe
      USD 103.1 Million

      Reasons to Buy this Report

      • Country-Level Market Breakdown : Access detailed market sizing for Germany, France, UK, Italy, Spain, and Rest of Europe. Understand regional variations in market maturity, reimbursement policies, and competitive dynamics to tailor market entry or expansion strategies.
      • Demographic & Clinical Insights : Gain comprehensive understanding of Europe's aging population trends, prevalence of venous and lymphatic disorders, and clinical adoption patterns. Identify high-opportunity segments based on disease epidemiology and patient demographics.
      • Regulatory & Reimbursement Analysis : Understand the complex European regulatory landscape, CE marking requirements, and country-specific reimbursement frameworks. Navigate healthcare system differences across major markets to optimize product positioning and pricing strategies.
      • Competitive Landscape Mapping : Identify leading compression therapy manufacturers, distributors, and emerging players across Europe. Analyze market consolidation trends, partnership opportunities, and competitive positioning in this mature, well-established market.
      • Growth Forecasts & Strategic Planning : Leverage 5-year market projections (2025-2030) to inform business planning, investment decisions, and resource allocation. Identify emerging opportunities in digital health integration, smart textiles, and preventive care solutions.

      Frequently asked questions

      What is the current size of Europe's compression therapy market in 2025?

      Europe's compression therapy market is valued at USD 1,341.1 million in 2025, reflecting strong demand for compression solutions across the region.

      What is the projected market size for compression therapy in Europe by 2030?

      Europe's compression therapy market is projected to reach USD 1,715.3 million by 2030, growing at a 5.0% CAGR from 2025 to 2030.

      What factors are driving growth in Europe's compression therapy market?

      Europe's market growth is driven by an aging population, rising prevalence of venous and lymphatic disorders, strong healthcare infrastructure, favorable reimbursement policies, and innovation in compression garment technology.

      Which conditions are most commonly treated with compression therapy in Europe?

      In Europe, compression therapy is primarily used to treat deep vein thrombosis, chronic venous insufficiency, lymphedema, and post-surgical swelling, supported by robust clinical evidence and healthcare guidelines.

      How does Europe's compression therapy market compare to other regions?

      Europe represents a mature and well-established compression therapy market with strong healthcare infrastructure, high clinical awareness, and favorable reimbursement policies that support consistent market growth.

      RESEARCH METHODOLOGY

      The size of the compression therapy market was based on four primary studies to ensure accuracy. Initial data for the compression therapy market and related sectors was gathered from 3 to 5 secondary sources. This information was then validated through primary research to confirm the assumptions and overall market sizing. Both top-down and bottom-up approaches were employed to determine the total market size, which was subsequently refined into segment and subsegment sizes. Finally, data triangulation was conducted to verify the accuracy of the findings.

      Secondary Research

      Secondary research sources included directories, Factiva, white papers, Bloomberg Business, annual reports, SEC filings, business filings, and investor presentations. These sources offered valuable insights into market leaders, sector divisions, and technological differences within various segments of the compression therapy industry.

      Primary Research

      Primary research consisted of both quantitative and qualitative insights gathered through interviews with key stakeholders. On the demand side, participants included physicians, researchers, department heads, and staff from diagnostic centers, hospitals, and research institutes. On the supply side, interviews were conducted with CEOs, area sales managers, territory and regional sales managers, and other top executives from relevant companies. These direct conversations helped validate the findings from secondary research and provided an opportunity to directly question and confirm assumptions.

      A breakdown of the primary respondents is provided below.

      Compression Therapy Market

      Note q: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      This report utilized the revenue share analysis of major companies to evaluate the size of the global compression therapy market. This analysis involved identifying key market participants and calculating their revenue from compression therapy using a variety of data collected during both primary and secondary research phases. One aspect of the secondary research included reviewing the annual and financial reports of leading market players. Conversely, primary research consisted of detailed interviews with influential thought leaders, including directors, CEOs, and key marketing executives.

      To determine the overall market value, the segmental revenue was calculated by mapping the revenue of the leading solution and service providers. The process involved several steps.

      • Making a list of leading international companies in the compression therapy industry
      • Charting annual profits made by leading companies in the compression therapy sector (or the closest stated business unit/product category)
      • 2024 revenue mapping of leading companies to cover a significant portion of the global market
      • Calculating the global value of the compression therapy industry

      Global Compression Therapy Market: Bottom-up and Top-down Approach

      Compression Therapy Market

      Data Triangulation

      To ensure accurate data, the compression therapy market was divided into various segments and subsegments. A data triangulation process that used both top-down and bottom-up approaches was applied. This involved analyzing factors and trends from both the demand and supply sides to validate the findings for each segment. The combination of this segmentation with the triangulation process helps ensure that the market data is both accurate and reliable.

      Market Definition

      Compression therapy is the process of applying controlled pressure to the lower extremities to increase and improve blood flow to the heart. This mode of treatment utilizes the elastic properties of compression garments or the pneumatic force of compression devices to address specific clinical requirements as part of disease management. The compression therapy market is primarily used for managing venous disorders, lymphedema, wound care, post-surgical recovery, and sports injuries. It enhances blood circulation, reduces swelling, and promotes healing, commonly through compression garments, bandages, and devices like pneumatic pumps. Key settings include hospitals, clinics, and home care.

      Stakeholders

      • Manufacturers of compression garments, bandages, and devices
      • Healthcare providers such as hospitals, clinics, and rehabilitation centers
      • Patients using compression therapy for various conditions
      • Healthcare professionals, including physicians, surgeons, and physiotherapists
      • Insurance companies involved in reimbursement and coverage
      • Regulatory bodies overseeing product standards and safety
      • Suppliers and distributors of compression therapy products
      • Research & development firms focusing on innovation and technology in compression therapy

      Report Objectives

      • To define, describe, and forecast the compression therapy market based on product, application, technique, distribution channel, and region
      • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the revenue of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players and comprehensively analyze their market ranking and core competencies
      • To benchmark players within the market using a proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio
      • To analyze competitive developments such as product launches, agreements, expansions, collaborations, and acquisitions in the compression therapy market

      Get the Full Compression Therapy Market Report

      Full forecast, segment splits, and company analysis for all Compression Therapy Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status